GAM
Griffin Asset Management’s iShares Biotechnology ETF IBB Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $400K | Hold |
3,165
| – | – | 0.05% | 166 |
|
|
2025
Q1 | $405K | Hold |
3,165
| – | – | 0.05% | 158 |
|
|
2024
Q4 | $418K | Hold |
3,165
| – | – | 0.05% | 168 |
|
|
2024
Q3 | $461K | Hold |
3,165
| – | – | 0.05% | 163 |
|
|
2024
Q2 | $434K | Hold |
3,165
| – | – | 0.05% | 165 |
|
|
2024
Q1 | $434K | Hold |
3,165
| – | – | 0.05% | 170 |
|
|
2023
Q4 | $430K | Hold |
3,165
| – | – | 0.05% | 167 |
|
|
2023
Q3 | $387K | Hold |
3,165
| – | – | 0.06% | 168 |
|
|
2023
Q2 | $402K | Hold |
3,165
| – | – | 0.05% | 169 |
|
|
2023
Q1 | $409K | Hold |
3,165
| – | – | 0.06% | 170 |
|
|
2022
Q4 | $416K | Hold |
3,165
| – | – | 0.06% | 164 |
|
|
2022
Q3 | $370K | Hold |
3,165
| – | – | 0.06% | 163 |
|
|
2022
Q2 | $372K | Hold |
3,165
| – | – | 0.06% | 170 |
|
|
2022
Q1 | $412K | Hold |
3,165
| – | – | 0.05% | 169 |
|
|
2021
Q4 | $483K | Hold |
3,165
| – | – | 0.06% | 172 |
|
|
2021
Q3 | $512K | Hold |
3,165
| – | – | 0.07% | 173 |
|
|
2021
Q2 | $518K | Hold |
3,165
| – | – | 0.06% | 178 |
|
|
2021
Q1 | $477K | Hold |
3,165
| – | – | 0.06% | 175 |
|
|
2020
Q4 | $479K | Hold |
3,165
| – | – | 0.06% | 162 |
|
|
2020
Q3 | $429K | Hold |
3,165
| – | – | 0.07% | 158 |
|
|
2020
Q2 | $433K | Hold |
3,165
| – | – | 0.07% | 157 |
|
|
2020
Q1 | $341K | Hold |
3,165
| – | – | 0.06% | 157 |
|
|
2019
Q4 | $381K | Hold |
3,165
| – | – | 0.05% | 170 |
|
|
2019
Q3 | $315K | Hold |
3,165
| – | – | 0.05% | 182 |
|
|
2019
Q2 | $345K | Sell |
3,165
-195
| -6% | -$21.3K | 0.04% | 198 |
|
|
2019
Q1 | $376K | Hold |
3,360
| – | – | 0.05% | 192 |
|
|
2018
Q4 | $324K | Sell |
3,360
-110
| -3% | -$10.6K | 0.05% | 185 |
|
|
2018
Q3 | $423K | Buy |
3,470
+305
| +10% | +$37.2K | 0.06% | 186 |
|
|
2018
Q2 | $348K | Hold |
3,165
| – | – | 0.06% | 171 |
|
|
2018
Q1 | $338K | Hold |
3,165
| – | – | 0.06% | 176 |
|
|
2017
Q4 | $338K | Buy |
3,165
+2,110
| +200% | +$225K | 0.06% | 174 |
|
|
2017
Q3 | $352K | Buy |
+1,055
| New | +$352K | 0.06% | 177 |
|